Neovacs SA(FR:ALNEV)
€0.080.00 (0.00%)
FR:ALNEV
Neovacs SA financials statements
€0.08
At close:0.00 (0.00%)
Want to see FR:ALNEV full AI Analyst Report?
Neovacs SA (ALNEV) Ratios
5 Followers
Neovacs SA Ratios
FR:ALNEV's free cash flow for Q4 2025 was €-2.60M. For the 2025 fiscal year, FR:ALNEV's free cash flow was decreased by €-1.18K and operating cash flow was €-2.60M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 23 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.84 | 1.03 | 0.63 | 1.80 | 7.52 |
| Quick Ratio | 0.84 | 1.03 | 0.63 | 1.80 | 7.52 |
| Cash Ratio | 0.18 | 0.24 | 0.11 | 0.01 | 3.51 |
| Solvency Ratio | -1.15 | -2.31 | -6.48 | -0.67 | -2.52 |
| Operating Cash Flow Ratio | -1.60 | -0.52 | -0.90 | -0.88 | -2.14 |
| Short-Term Operating Cash Flow Coverage | -9.37 | -2.94 | -15.63 | -3.71 | -9.91 |
| Net Current Asset Value | € -1.46M | € 97.82K | € -1.50M | € 4.04M | € 30.12M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 |
| Debt-to-Equity Ratio | 0.03 | 0.01 | 0.01 | 0.03 | 0.02 |
| Debt-to-Capital Ratio | 0.03 | 0.01 | 0.01 | 0.03 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 |
| Financial Leverage Ratio | 1.23 | 1.08 | 1.22 | 1.11 | 1.11 |
| Debt Service Coverage Ratio | -3.13 | -4.57 | -0.27 | -1.57 | -3.25 |
| Interest Coverage Ratio | -5.79 | -6.86 | -0.33 | -11.00 | -3.92 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.04 | 47125.53 | 1213306.47 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.01 | 0.03 | 0.03 | -0.32 | 1.47 |
| Profitability Margins | |||||
| Gross Profit Margin | -2796.53% | -1266.26% | 11.58% | -563037.68% | -33620.50% |
| EBIT Margin | -3354.77% | -1614.78% | -3699.40% | -338116.91% | -46373.03% |
| EBITDA Margin | -3239.99% | -1584.06% | -1804.67% | -324511.24% | -45933.23% |
| Operating Profit Margin | -3354.77% | -1294.97% | -1846.44% | -579583.27% | -34695.90% |
| Pretax Profit Margin | -3415.45% | -1803.52% | -9266.77% | -390822.03% | -55226.16% |
| Net Profit Margin | -3026.84% | -1639.16% | -8984.51% | -319109.98% | -52389.03% |
| Continuous Operations Profit Margin | -3026.84% | -1639.15% | -8984.51% | -319109.98% | -52389.03% |
| Net Income Per EBT | 88.62% | 90.89% | 96.95% | 81.65% | 94.86% |
| EBT Per EBIT | 101.81% | 139.27% | 501.87% | 67.43% | 159.17% |
| Return on Assets (ROA) | -22.12% | -18.39% | -149.13% | -7.20% | -24.38% |
| Return on Equity (ROE) | -27.15% | -19.95% | -182.23% | -8.02% | -26.96% |
| Return on Capital Employed (ROCE) | -28.59% | -15.76% | -37.44% | -14.57% | -17.85% |
| Return on Invested Capital (ROIC) | -24.64% | -14.12% | -35.84% | -11.57% | -16.55% |
| Return on Tangible Assets | -22.12% | -18.39% | -149.14% | -7.20% | -24.38% |
| Earnings Yield | -0.15% | -1.24% | -18.98% | 0.00% | 0.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.08 | 0.19 | 0.71 | 0.00 | 0.01 |
| Payables Turnover | 2.50 | 3.68 | 0.14 | 3.25 | 5.77 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.69 | 1.01 | 0.88 | 0.00 | 0.04 |
| Asset Turnover | 0.01 | 0.01 | 0.02 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | -0.16 | 0.26 | -0.52 | 0.00 | 0.00 |
| Cash Conversion Cycle | 4263.98 | 1802.62 | -2051.79 | 593639.24 | 25777.25 |
| Days of Sales Outstanding | 4409.97 | 1901.88 | 511.82 | 593751.61 | 25840.53 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 145.99 | 99.26 | 2563.60 | 112.36 | 63.28 |
| Operating Cycle | 4409.97 | 1901.88 | 511.82 | 593751.61 | 25840.53 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.13 | -54400.07 | -211836.47 | 0.00 | 0.00 |
| Free Cash Flow Per Share | -0.13 | -60183.52 | -216525.06 | 0.00 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | -809.99 | -9.41 | -45.18 | -29.12 | -28.40 |
| Capital Expenditure Coverage Ratio | -809.99 | -9.41 | -45.18 | -29.12 | -28.40 |
| Operating Cash Flow Coverage Ratio | -9.37 | -2.94 | -15.63 | -3.69 | -9.63 |
| Operating Cash Flow to Sales Ratio | -31.11 | -3.59 | -9.83 | -4000.46 | -438.48 |
| Free Cash Flow Yield | -0.15% | -0.30% | -2.12% | 0.00% | 0.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -669.23 | -80.45 | -5.27 | 0.00 | 0.00 |
| Price-to-Sales (P/S) Ratio | 20138.85 | 1318.62 | 473.32 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 180.66 | 16.05 | 9.60 | 0.00 | 0.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -646.50 | -332.32 | -47.11 | 0.00 | 0.00 |
| Price-to-Operating Cash Flow Ratio | -647.30 | -367.65 | -48.15 | 0.00 | 0.00 |
| Price-to-Earnings Growth (PEG) Ratio | 6.69 | -0.00 | 0.05 | 0.00 | 0.00 |
| Enterprise Value Multiple | -621.56 | -83.22 | -26.20 | -0.32 | 1.47 |
| Enterprise Value | 3.26B | 703.13M | 173.19M | 1.16M | -15.22M |
| EV to EBITDA | -621.56 | -83.22 | -26.20 | -0.32 | 1.47 |
| EV to Sales | 20138.64 | 1318.18 | 472.76 | 1043.97 | -673.65 |
| EV to Free Cash Flow | -646.50 | -332.21 | -47.05 | -0.25 | 1.48 |
| EV to Operating Cash Flow | -647.29 | -367.52 | -48.09 | -0.26 | 1.54 |
| Tangible Book Value Per Share | 0.48 | 1246020.79 | 1062454.29 | 0.00 | 0.00 |
| Shareholders’ Equity Per Share | 0.48 | 1246045.70 | 1062480.24 | 0.00 | 0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.11 | 0.09 | 0.03 | 0.18 | 0.05 |
| Revenue Per Share | 0.00 | 15167.35 | 21549.76 | 0.00 | 0.00 |
| Net Income Per Share | -0.13 | -248616.44 | -1936141.71 | 0.00 | 0.00 |
| Tax Burden | 0.89 | 0.91 | 0.97 | 0.82 | 0.95 |
| Interest Burden | 1.02 | 1.12 | 2.50 | 1.16 | 1.19 |
| Research & Development to Revenue | 0.00 | 8.38 | 10.94 | 2248.34 | 186.79 |
| SG&A to Revenue | 0.48 | 0.00 | -10.83 | 0.00 | 180.53 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.03 | 0.22 | 0.11 | 1.25 | 0.84 |
Currency in EUR
